A company is not sold on it's present stock price. It is sold on multiples of it's earnings or in this case, it's future worth to the company acquiring it. The present stock price has only a small percentage to do in the negotiation. In this case, just the breast cancer indication has proven to be worth over $30 a share to CYDY. $10 would not even be brought to the board. You have to be realistic and not shoot for the sky but also not take crumbs just because you don't know the game and feel pain. That's part of the acquiring company's strategy.